Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Tumor protein p73 (TP73) is a member of the p53 family of transcription factors, playing a critical role in regulating cellular responses to stress, cell cycle control, apoptosis, and development. It produces several isoforms, notably TAp73 (tumor suppressive) and ΔNp73 (oncogenic), with the balance between these isoforms crucial for tumor suppression versus oncogenic potential. TP73 is rarely mutated in cancers, but its dysregulation contributes to tumorigenesis. It interacts with various proteins and participates in intrinsic apoptotic signaling pathways.
Modulation of TAp73/ΔNp73 isoform balance; activation of TAp73
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Tumor protein p73 (TP73).